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Conflicting data have been published regarding 
the rate of postangtoplasty restenosis observed in 
diverse segments of the coronary tree. However, 
these studies may be criticized for their biased see- 
lection of patients, methods of analysis, and defi- 
nitions of restenosis. In the present study, 1,353 
patients underwent a successful coronary ditata- 
tion of Ll site. In all, 1,234 patients (91%) had a 
follow-up angiogram after 6 months, or earlier 
when indicated by symptoms. All films were pro- 
cessed and analyzed at the thoraxcenter core lab- 
oratory with the coronary angiography analysis 
system (automated contour detection). Restenosis 
was considered present if the diameter stenosis at 
follow-up was >50%. No differences in restenosis 
rates were observed between coronary segments 
using this categorical defhrition. A conthmous ap- 
proach was also used; absolute changes in mini- 
mal luminal diameter adjusted for vessel size were 
used in order to allow comparison between vesseis 
of diirent sizes (relative loss). No significant dif- 
ferences were observed between the coronary seg- 
ments with this continuous approach. These re- 
sults suggest that restenosis is a ubiquitous phe- 
nomenon without any predilection for a particular 
site in the coronary tree. 
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ver since the introduction of percutaneous translu- E minal coronary angioplasty (PTCA)’ as an alter- native to coronary artery bypass grafting, this 
means of treatment has been plagued by the problem of 
restenosis, which has become an important field of in- 
vestigation in interventional cardiology. During the last 
14 years clinicians have searched extensively for factors 
increasing the risk of restenosis, and many patient-la 
sion-procedure-related factors have been put forward.2$ 
However, the cause and effect relation of these factors 
can be questioned, because these early studies were, 
in general, retrospective analyses with relatively small 
numbers of patients. In addition, these studies were 
fraught with methodologic problems; angiographic fol- 
low-up was incomplete, incidence of restenosis was in- 
fluenced by the recurrence of symptoms, and time for 
restudy was not predetermined. Furthermore, the deli- 
nition of restenosis varied between the different studies, 
and presence or absence of restenosis was assessed visu- 
ally, a method known to be limited by inter- and in- 
traobserver variability. 4~5 One risk factor for restenosis 
that led to controversy is the site of dilatation, with 
some studies finding a higher incidence of restenosis in 
the proximal left anterior descending coronary artery 
(LAD) as compared with the right or left circumflex 
coronary artery (LC) (Table I).6-19 Recently, 2 multi- 
center restenosis prevention trials enrolled >1,400 pa- 
tients who were analyzed at the same angiographic core 
laboratory. In 91% of these patients, follow-up angiog- 
raphy was performed, and the same quantitative coro- 
nary angiographic method of analysis was u~ed.~~~~ The 
present study investigates whether the previously report- 
ed differences in restenosis rates in the 3 major coro- 
nary arteries could be confirmed in this large study 
group. 
METHOD5 
The study population consisted of 1,442 patients 
with significant primary stenoses in native coronary 
arteries who were prospectively enrolled in 2 restenosis 
trials in Europe. Because no angiographic or clinical 
benefit of the 2 tested compounds could be demon- 
strated, the control and active treatment groups were 
pooled for the present study. PTCAs and follow-up 
films of all patients with successful dilations were ana- 
lyzed at the thoraxcenter core laboratory. Informed 
consent was obtained in all cases before the PTCA pro- 
cedure, and all patients were asked to return to the hos- 
pital for follow-up angiography. Patients with stable 
and unstable angina pectoris, and those with totally oc- 
cluded vessel segments were included in the study. Pa- 
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TABLE I Summary of Restenosis Studies Demonstrating Conflicting Results as to the Site of Dilatation as a Risk Factor for Restenosis 
Angio Fup Restenosis 
Study Year Patients (%) Definition of Restenosis (%) Coronary Artery Statistical Analysis 
Holmes6 1984 665 84 NHLBI I-IV 33.6 No difference Multivariate 
KaltenbachT* 1985 356 94 DS Fup < 20% DS pre 12 No difference Univariate 
Decrease 2 50% of gain 16 
t DS 230% 17 
Matas? 1985 63 95 t DS >30% 23 LAD or LC > right Multivariate 
or DS > 70% 
DiSciasciogt 1986 191 21T Decrease t 50% of gain 58 l-‘/D No difference Univariate 
42 2-VD 
LeimgruberlO 1986 1,758 57 > 50% DS 30.2 LAD > right > LC Multivariate 
MylerllS 1987 286 57 > 50% DS 41 No difference Multivariate 
Val12 1987 181 98 T r 30% DS 28 No difference Multivariate 
Vandormaells$ 1987 209 62 > 50% DS 82 Wmp) LAD > right or LC Multivariate 
30 (No Symp) Prox > Dist 
Black145 1988 384 39 > 50% DS 31 No difference Multivariate 
de FeyterlsII 1988 179 88 > 50% DS 32 LAD > right or LC Multivariate 
Fleck’s* 1988 110 86 AMLCA > 1 mm2 WA) 58 No difference Multivariate 
Quigley17§ 1989 114 88 > 50% DS 32 No difference Multivariate 
Renkinla 1990 278 47** > 50% DS - No difference Multivariate 
Rupprechtlg* 1990 676 70 > 50% DS or 29.2 No difference Multivariate 
decrease > 50% of gain 
Present study 1991 1,353 91 > 50% DS 31 No difference Univariate 
Relative loss 0.11 ” 0.21 Analysis of variance 
*Excluded total occlusions; tmultivessel dilatation; tmultilesion dilatation; (for restenosis; I/unstable angina: Tlreview of patients with clinical recurrence; l *angiography + exercise 
thallium scintigraphy. 
Anglo Fup = % of patlents with an&graphic follow-up; Dist = distal; DS = diameter stenosis; LAD = left anterior descending; LC = kft cinumflex; AMLCA - chanp in minimal 
luminal cross-sectional area: NHLBI = National Heart, Lung, and Blood Institute; pre = before; Pmx = pmximal; PCA = quantitabve cornnary angiographic method of analysis; RCA = 
right comnary artefy; Symp = symptoms; VO = vessel disease. 
tients with developing myocardial infarctions and signif- 
icant left main disease were excluded from the study. 
PTCA was successful if the final diameter stenosis 
was <50% on visual inspection of the angiogram after 
PICA. PTCA was considered complete when the guid- 
ing catheter was removed from the groin. When recur- 
rence of chest pain during the hospital stay led to core 
nary reintervention, the film before reintervention was 
used as the follow-up angiogram. If a follow-up angio- 
gram was obtained before 3 months and if no definite 
restenosis had occurred, the patient was asked to under- 
go another coronary angiogram at 6 months. 
Figure 1 describes the flow chart of all 1,442 ran- 
domized patients. Of the 1,353 patients with successful 
PTCA, 1,234 patients had a follow-up angiogram after 
6 months, or earlier when indicated for symptoms. 
Pemameoustr- - angw-v 
proccnlre Md Maphk w At the beginning 
of the procedure, all patients received a bolus of intrave- 
nous heparin (10,000 IU). After 2 hours, an additional 
infusion of heparin (5,000 IU/hour) was administered 
until the end of the procedure. Use of a calcium antago- 
nist for 48 hours was permitted. Choice of balloon type, 
inflation duration and pressure was left to the discretion 
of the operator. 
Three angiograms were obtained of each patient (1 
immediately before and 1 immediately after PTCA, 
and 1 at follow-up). The angiograms were recorded in _ _ . -_ - . . 
1 
and at follow-up, measures were taken as described pre- 
viously.S~*O 
All cineangiograms were quantitatively analyzed us- 
ing the coronary angiography analysis system that has 
been validated and described in detail previously.5~20 
The absolute values of the stenosis diameter as well as 
the reference diameter are measured by computer using 
the known contrast-emntv catheter diameter as a scal- 
I 
1442 PATIENTS 
1353 PATIENTS 
such a way that they were suitable for quantitative -,mwwadYmw-Thl3,pa- 
analysis by the coronary angiography analysis system. m M w angb@dy (PTCA) wn nd 
An example of an analysis is shown in Figure 2. To pwtonnd, md in *, -~(QWW~-~P- 
standardize the method of data acquisition and to en- 
dbb.hglop&kfobwup(~AWQlo)wnoWndh 
sure exact reproducibility of angiograms after FTCA 
1~~m%)--coronry~in 
1,333. 
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ing device. For that purpose, the catheter tips were re- 
tained for accurate measurement with a micrometer. To 
achieve maximal vasodilation, either nitroglycerin (0.1 
to 0.3 mg) or isosorbide dinitrate (1 to 3 mg) was ad- 
ministered for each coronary artery involved before and 
after RICA, and at follow-up angiography. All contour 
positions of the catheter and the arterial segment were 
corrected for pincushion distortion introduced by the 
image intensifiers. Because the algorithm is not able to 
measure total occlusions and lesions with Thrombolysis 
in Myocardial Infarction-l perfusion, a value of 0 mm 
was substituted for the minimal luminal diameter and 
100% for the percent diameter stenosis. In these cases, 
the reference diameter after PTCA was substituted for 
the reference diameter before PTCA or at follow-up. 
For each dilated segment, the minimal luminal diame- 
ter and diameter stenosis before and after PTCA, and 
at follow-up were taken as the mean value from multi- 
ple matched projections5 
Definition of eomnary segmen& Austen et a121 di- 
vided the coronary tree in 15 different segments (Figure 
3). Because dilatation of the distal vessel segments did 
not occur frequently, it was decided to regroup these 
distal segments. The right coronary artery was divided 
in 4 segments; segment 1 corresponded with the proxi- 
mal, segment 2 with the middle, and segments 3 and 4 
were taken together as the distal right coronary artery. 
The LAD was divided in 5 segments; segment 6 corm- 
sponded with the proximal LAD, segment 7 with the 
middle LAD, and segments 8, 9 and 10 were taken to- 
gether as the distal LAD. The LC was divided in 5 seg- 
ments; segment 11 corresponded with the proximal LC, 
segments 13 and 15 were taken together as the middle 
LC, and segments 12 and 14 were taken together as the 
distal LC. 
kdillitiOll Of r&SllOSiS: CATEGORICAL APPROACH: 
Many criteria have been proposed by the National 
Heart, Lung, and Blood Institute to assess restenosis. 
The most frequently used criterion by clinicians is that 
restenosis is present when the diameter stenosis is >50% 
at follow-up angiography.22 This definition was used for 
our data. 
CONTINUOUS APPROACH: In addition to this arbitrary 
categorical approach for restenosis, we wanted to use 
absolute changes in minimal luminal diameter adjusted 
for vessel size, which allows for comparison between 
vessels of different sizes and is a reflection of how the 
lesion behaves during and after RICA. 
Relative gain depicts the increase in minimal lumi- 
nal diameter normalized for the reference diameter dur- 
ing PTCA (minimal luminal diameter [before PTCA - 
after FTCA]/reference diameter before RTCA). Rela- 
tive loss depicts the decrease in minimal luminal diame 
ter normalized for the reference diameter (minimal lu- 
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minal diameter [after PTCA - at follow-up]/reference 
diameter before PTCA) (Figure 4). 
Data analysis: Data were analyzed using the bio- 
medical-designed program statistical software package 
(University of California Press, Berkeley, California, 
1990). A chi-square test was used to assess differences 
in categorical variables. A l-way analysis of variance 
was used to assess differences in continuous variables 
among the 3 major coronary arteries and the 9 different 
segments of the coronary tree. A p value <0.05 was 
considered indicative of a significant difference. 
RESULTS 
The mean time to follow-up angiography was 165 f 
42 days. In 1,234 patients, 1,452 lesions were success- 
fully dilated (1.2 lesions/patient). In 74 patients, a to- 
tally occluded vessel segment was dilated. In 1,137 pa- 
tients, l-vessel dilatation was performed, 93 had 2-ves- 
se1 dilatation, and 4 had all 3 vessels dilated. The 
majority of stenoses were located in the LAD (684 le- 
sions) compared with 414 lesions in the right coronary 
artery and 354 in the LC. 
RESTENOSIS PER VESSEL SEGMENT (N-1452) 
% 6(288) 
*m DIAMETER STENOSIS J 50% AT FUP 
RELATIVE LOSS PER VESSEL SEGMENT 
(N-1452) 
Bpit?% RELATIVE LOSS : A MLD/ REF DIAM 
Table II lists the results of the quantitative measure- 
ments of the 1,452 lesions. The largest vessel was the 
right coronary artery, with an average reference diame- 
ter of 2.86 f 0.55 mm. The LAD and LC had similar 
sizes; the average reference diameters were 2.54 f 0.53 
mm for the LAD, and 2.55 f 0.50 mm for the LC (p 
<O.OOl). In addition, the average increases in minimal 
luminal diameter were 0.82 f 0.37 mm in the right cor- 
onary artery, 0.71 f 0.36 mm in the LAD, and 0.72 f 
0.35 mm in the LC. If these values were “normalized 
for the reference diameter” (relative gain), no signifi- 
cant differences were observed among either the 3 ma- 
jor coronary arteries (right coronary artery vs LAD vs 
LC; p = 0.44) or the different segments of the coronary 
tree (p = 0.77). During follow-up, the average losses in 
minimal luminal diameter were 0.26 f 0.55 mm in the 
right coronary artery, 0.30 f 0.48 mm in the LAD, and 
0.25 f 0.48 mm in the LC. If these values were normal- 
ized for the reference diameter (relative loss), no signifi- 
cant differences were observed among the 3 major coro- 
nary arteries (right coronary artery vs LAD vs LC; 
p = 0.13) or the different segments of the coronary tree 
(p = 0.19). 
The restenosis rate, and relative gain and loss for the 
3 major coronary arteries and the diverse vessel seg- 
ments, using either the categorical or continuous ap 
preach, are listed in Table III. No significant difference 
in either approach was observed. 
DISCUSSION 
Several investigators have raised the question as to 
whether the dilated vessel constitutes a risk factor for 
the development of restenosis. They have reported con- 
flicting results (Table I). The question is becoming even 
more relevant as new interventional techniques (such as 
stenting, atherectomy, laser photoablation and rotabla- 
tion) have been “claimed” to be more effective than 
conventional balloon angioplasty in certain lesion types 
(long lesions and total occlusions), locations or vessels 
(right coronary artery, LAD, LC and bypass graft),23 
i 3.0 MM 
RD 
I 
RELATIVE GAIN AND RELATIVE LOSS 
1 1.0 MM ~ / 2.2 MM 1 ( 1.6 MM 
MLD PRE MLD POST MLD FUP 
I?GAIN.~~~;~ n +.r$ RLOSS. AMLDFUP . g .o,2 
RD 
FIGURE 4. See text for expbath of dative gain @GAIN) 
end rebtire bee (NLD3s). FUP = fobwup; MID = minimd 
hmind~PDST=afteqPRE=befom;PTCA=percu- 
t4MWUStranrkmindClUUNUY~ND=rafarencadi- 
em&r. 
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although these new techniques have not yet succeeded 
in reducing restenosis rates.24*25 Several explanations 
ma1 selection of the balloon/artery ratio and optimal 
have been put forward to explain the increased risk for 
balloon pressure application. They suggested that ana- 
restenosis in the (proximal) LAD. Mata et al* believed 
tomic or procedural factors were responsible for reste- 
that a high rate of “continuous success” needs an opti- 
nosis. Leimgruber et allo had 3 possible explanations. 
First, because they believed that the proximal LAD is 
TABLE II Baseline Quantitative Angiographic Data per Vessel Segment Dilated 
Coronary Pre PTCA RD Post PTCA RD Follow-Up RD Pre PTCA MLD Post PTCA MLD Follow-Up MLD 
Artery No. (mm) (mm) (mm) (mm) (mm) (mm) 
Total 1,452 2.63 2 0.54 2.70 + 0.52 2.70 + 0.56 1.02 f 0.38 1.77 ‘- 0.36 1.50 + 0.57 
Right 414 2.86 2 0.55 2.93 + 0.52 2.97 2 0.58 1.08 2 0.41 1.91 * 0.37 1.65 2 0.65 
Proximal 148 2.99 + 0.55 3.05 f 0.51 3.07 2 0.55 1.11 f 0.45 1.96 f 0.39 1.69 f 0.63 
Middle 174 2.82 f 0.50 2.90 + 0.50 2.94 + 0.59 1.08 + 0.41 1.91 + 0.34 1.66 f 0.65 
Distal 92 2.71 k 0.59 2.81 f 0.56 2.85 f 0.57 1.02 f 0.35 1.83 f 0.40 1.57 2 0.66 
LAD 684 2.54 + 0.53 2.59 2 0.49 2.58 f 0.53 1.01 f 0.36 1.72 + 0.35 1.42 2 0.53 
Proximal 288 2.73 + 0.52 2.78 + 0.48 2.76 f 0.53 1.08 f 0.35 1.83 f 0.35 1.53 f 0.55 
Middle 324 2.48 + 0.47 2.52 + 0.43 2.52 f 0.47 0.97 -t 0.36 1.68 f 0.32 1.35 -+ 0.51 
Distal 72 2.08 + 0.44 2.14 + 0.44 2.13 t 0.42 0.87 2 0.35 1.43 -1- 0.29 1.29 f 0.37 
LC 354 2.55 2 0.50 2.62 f 0.46 2.61 + 0.48 1.01 f 0.36 1.73 f 0.34 1.48 f 0.51 
Proximal 101 2.73 + 0.47 2.75 +- 0.43 2.74 2 0.44 1.06 ‘- 0.42 1.82 f 0.32 1.52 + 0.50 
Middle 125 2.55 + 0.50 2.64 ‘- 0.45 2.61 f 0.50 1.00 f 0.34 1.75 f 0.32 1.52 + 0.53 
Distal 128 2.41 f 0.49 2.50 f 0.46 2.52 f 0.48 0.98 + 0.34 1.63 ir. 0.34 1.41 + 0.49 
Values are means k standard deviation. 
LAD = leftanteriordescendlng; LC = left circumflex; MLD = mmimal luminal diameter; Post = after; Pre = before; PTCA = percutaneous transluminal coronaryangioplasty; RD = 
reference diameter. 
TABLE III Restenosis Rate per Segment Using the Categorical Definition of > 50% DS at Follow-Up, and the Continuous Approach 
with Relative Gain and Loss 
DS (%) at Follow-Up > 50% 
No. Yes No Relative Gain Relative Loss 
Right 414 
Proximal 148 
Middle 174 
Distal 92 
LAD 
Proximal 
Middle 
Distal 
684 224 (33) 
288 95 (33) 
324 114 (35) 
72 15 (21) 
LC 
Proximal 
Middle 
Distal 
p Value 
354 97 (28) 
101 33 (33) 
125 25 (20) 
128 40 (31) 
(right vs LAD vs LC) 0.22 
(9 segments) 0.06 
1452 444 (31) 
123 (30) 
45 (30) 
48 (28) 
30 (33) 
1008 (69) 
289 (70) 
103 (70) 
126 (72) 
62 (67) 
457 (67) 
193 (67) 
210 (65) 
57 (79) 
255 (72) 
68 (67) 
100 (80) 
88 (69) 
0.29 f 0.16 
0.30 f 0.15 
0.29 + 0.15 
0.30 + 0.15 
0.31 + 0.15 
0.29 f 0.17 
0.29 + 0.17 
0.29 + 0.17 
0.27 f 0.19 
0.29 f 0.16 
0.29 IT 0.16 
0.30 f 0.15 
0.28 2 0.17 
0.44 
0.77 
0.11 2 0.21 
0.10 f 0.22 
0.10 f 0.21 
0.10 f 0.22 
0.11 f 0.26 
0.12 f 0.20 
0.12 f 0.19 
0.13 + 0.21 
0.07 + 0.15 
0.11 f 0.21 
0.11 k 0.18 
0.09 f 0.21 
0.09 f 0.21 
0.13 
0.19 
Values are means + standard deviation. 
Abbreviations as in Table I. 
TABLE IV Relative Gain and Loss per Reference Diameter Group 
DS (%) at Follow-Up > 50% 
RD (mm) No. Absolute Gain (mm) Relative Gain Absolute Loss (mm) Relative Loss Yes No BAR 
>4.0 mm 18 0.72 f 0.55 0.17 + 0.13 0.13 2 0.46 0.03 f 0.10 6 (33) 12 (67) 0.77 
3.5 to4.0 mm 81 0.87 2 0.47 0.24 + 0.13 0.10 ” 0.50 0.03 2 0.13 23 (28) 58 (71) 0.89 
3.0 to 3.5 mm 222 0.83 f 0.42 0.26 f 0.13 0.33 2 0.54 0.10 f 0.17 71 (32) 151(68) 0.97 
2.5 to 3.0 mm 507 0.76 2 0.40 0.28 f 0.15 0.28 2 0.52 0.10 e 0.19 153 (30) 354 (70) 1.07 
2.0 to2.5 mm 454 0.72 2 0.40 0.32 f 0.17 0.28 k 0.51 0.12 f 0.23 148 (33) 306 (67) 1.20 
c2.0 mm 170 0.61 t 0.34 0.34 -t 0.20 0.27 2 0.46 0.15 f 0.26 44 (26) 126 (74) 1.39 
Analysis of variance <O.OOl <O.OOl <0.02 <O.OOl NS 
Values are means + standard deviation. 
BAR = balloon-artery ratio (size of the balloon according to manufacturer divided by the reference diameter before percutaneous transluminal coronary angioplasty); DS = diameter 
stenosis; NS = not significant: RD = reference diameter. 
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most often the largest artery, the 3.0 mm diameter bal- 
loons most frequently used at that time could have been 
undersized for the LAD and oversized for the right cor- 
onary artery and LC. This resulted in increased diame- 
ter stenosis after PTCA, which seems to be associated 
with a higher risk for restenosis. Second, a dilatation of 
the proximal LAD often involves the origin of the vessel 
and vessel branch points, and this factor also appears to 
be associated with an increased risk of restenosis. Third, 
the proximal LAD is well-recognized to develop “local- 
ized stenosis.” Whether the same underlying mecha- 
nisms may predispose a patient to recurrence of lesions 
after angioplasty is unknown but well-conceivable. 
Because balloon/artery mismatch was not identified 
as a predictor for restenosis in a group of patients with 
multilesion coronary angioplasty, Vandormael et al1 3 
suggested that the different anatomic and structural 
features of the proximal segment of the LAD compared 
with those of the proximal segment of the right coro- 
nary artery or LC may be responsible for the observa- 
tion that dilatation of the proximal LAD is an indepen- 
dent risk factor for restenosis. 
According to Califf et a1,3 1 of the methodologic ca- 
veats for an increased rate of restenosis in the proximal 
LAD was that an ischemic response to exercise testing 
was more likely to be seen with proximal LAD lesions, 
thereby increasing the chance of preferential detection 
unless angiographic follow-up was complete. Also, a 
larger diameter of this vessel may have increased the 
risk that a satisfactory initial result was not achieved in 
earlier series, especially before the recent development 
of larger balloons to approach large vessels. 
In the present study, no significant difference in the 
restenosis rate was found among the 3 major coronary 
arteries (p = 0.22) or the 9 coronary artery segments 
(p = 0.06) selected for the purpose of analysis. Our re- 
sults contradict the earlier observations of Leimgruber 
and Califf and their coworkers that the proximal LAD 
is the largest vessel. In the present study, almost every 
segment of the right coronary artery has a larger diame- 
ter than the proximal LAD. An explanation for this dis- 
crepancy may be the differences in patient populations; 
availability of different balloon sizes (with diameters 
<2.0 mm as compared with those in the early days of 
PTCA when only balloon sizes of 3.7 mm were avail- 
able) for dilatation may have affected PTCA of the 
proximal LAD. Another argument put forth in the ear- 
ly years that there was a mismatch between balloon 
catheters and proximal LAD is no longer valid, because 
in the present study, all patients underwent PTCA be- 
tween December 1987 and December 1989 so that in all 
cases matched balloons were available. The differences 
in restenosis rates reported by these investigators are 
probably more related to the biased and incomplete an- 
giographic follow-ups of these studies. In contrast, 
the present study has a 91% angiographic follow-up 
rate, and so the biased selection of symptomatic versus 
asymptomatic patients is virtually ruled out. 
Definition of restenosis: The definition of restenosis 
has been the subject of much debate.4 Of the different 
restenosis criteria proposed, >50% diameter stenosis 
at follow-up angiography is the most frequently used 
to assess restenosis, because physiologic measurements 
have shown that the threshold for chest pain is near a 
reduction of 50% of the lumen of a normal vesse1.22 This 
definition was applied to our data. However, earlier 
studies have shown that the reference diameter can be 
involved in the dilatation process so that the % diameter 
stenosis could underestimate the change in the severity 
of a stenosis after PTCA.26 Furthermore, the 50% di- 
ameter stenosis criterion at follow-up reveals nothing 
about the way the lesion has behaved since the PTCA 
procedure. We have previously shown that a change 
LO.72 mm in minimal luminal diameter is an appropri- 
ate method to assess intimal hyperplasia after coronary 
PTCA.5,20,27 However, this criterion was historically as- 
sessed in vessels with an average reference diameter of 
3.7 mm.5+20 Therefore, it should be applied to vessels of 
comparable reference diameter; it is unlikely to have a 
decrease 20.72 mm in coronary segments with a refer- 
ence diameter of 2 mm, and a minimal luminal diame- 
ter of 1.4 mm. In other words, criteria based on the 
absolute change in minimal luminal diameter are limit- 
ed because they make no attempt to relate the extent of 
the restenosis process to the size of the vessel. To cir- 
cumvent this limitation it was proposed to use the 
change in minimal luminal diameter from after PTCA 
to follow-up, normalized for the reference diameter (rel- 
ative loss). This sliding scale criterion that adjusts for 
vessel size allows for regional assessment of the extent 
of the restenosis phenomenon in the entire coronary 
tree. No difference in relative loss among the 3 major 
coronary arteries (p = 0.13) or the coronary segments 
could be observed (p = 0.19). Restenosis should thus be 
viewed as a ubiquitous phenomenon that is inducible to 
the same extent in every segment of the coronary tree. 
It must be emphasized that the relative gain (change in 
minimal luminal diameter from before to after PTCA, 
normalized for the reference diameter) and thus the 
stimulus for restenosis28 were similar in every segment 
of the coronary tree. 
Because the subdivision of the American Heart As- 
sociation-coronary segments is somewhat arbitrary in 
that vessels of different diameters are grouped together, 
we reanalyzed the data by stratifying the lesions accord- 
ing to their reference diameters. Table IV lists the re- 
sults. It appears that the larger the reference diameter is 
before PTCA, the smaller the relative loss is at follow- 
up; vice versa, the greatest value of relative loss is ob- 
served in the smaller vessels. This may be explained by 
oversizing of the balloon in these vessels. However, if 
the restenosis criterion of X0% diameter stenosis is 
used, then similar restenosis rates are found. 
Potential limitation of the studyr Our study popula- 
tion consisted mainly of patients with 1 dilatation site; 
1,044 patients had 1 dilatation site, and 190 underwent 
dilatation of 12 sites. The high incidence of 1 dilatation 
site reflects the fact that the study population included 
in these 2 trials consisted predominantly of patients with 
l-vessel disease, so that our findings may not be extrap- 
olated to a population with multivessel disease. Never- 
theless, in the subset of 93 patients with multivessel di- 
latation, the overall restenosis rate per lesion was also 
31%. However, the relative gain and loss observed in 
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patients with l- and 2-vessel dilatations differed statisti- 
cally; a relative gain of 0.30 f 0.16 was seen for l-vessel 
dilatation versus 0.27 f 0.16 for 2-vessel dilatation (p 
<0.04), and a relative loss of 0.12 f 0.21 for l-vessel 
dilatation versus 0.08 f 0.20 for 2-vessel dilatation (p 
<0.02). Thus, in the population with 2-vessel dilatation, 
a reduced gain is associated with a reduced loss consis- 
tent with the concept that PTCA operators are less ag- 
gressive in their dilating strategy. 
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